Free Trial
ASX:ACR

Acrux (ACR) Stock Price, News & Analysis

Acrux logo

About Acrux Stock (ASX:ACR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
4,000 shs
Average Volume
N/A
Market Capitalization
A$12.47 million
P/E Ratio
N/A
Dividend Yield
11.66%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acrux and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACR Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
South African group buys Cononish gold mine
See More Headlines

ACR Stock Analysis - Frequently Asked Questions

Acrux Limited (ASX:ACR) announced its quarterly earnings results on Thursday, February, 21st. The company reported ($0.02) earnings per share (EPS) for the quarter. Acrux had a negative net margin of 113.93% and a negative trailing twelve-month return on equity of 130.13%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acrux investors own include Altimmune (ALT), ANZ Group (ANZ), Lynas Rare Earths (LYC), MV Oil Trust (MVO), Organigram (OGI), BHP Group (BHP) and Beacon Roofing Supply (BECN).

Company Calendar

Last Earnings
2/21/2019
Today
8/30/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Trading
Current Symbol
ASX:ACR
CIK
N/A
Fax
N/A
Employees
2,018
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$5.80 million
Net Margins
-113.93%
Pretax Margin
N/A
Return on Equity
-130.13%
Return on Assets
-48.18%

Debt

Debt-to-Equity Ratio
113.06
Current Ratio
1.61
Quick Ratio
2.89

Sales & Book Value

Annual Sales
A$5.09 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.57
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
290,720,000
Free Float
N/A
Market Cap
A$12.47 million
Optionable
Not Optionable
Beta
1.21
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (ASX:ACR) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners